Trials / Active Not Recruiting
Active Not RecruitingNCT06483685
Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety
Global Insights Into Therapeutic Radiopharmaceuticals Safety: A Comprehensive Analysis From the WHO Pharmacovigilance Database (RADIANTS)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500,000 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Little is known about cancer therapy-related radiopharmaceuticals drugs safety. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related radiopharmaceuticals drugs.
Detailed description
Radiopharmaceuticals drugs especially for therapeutic purposes are responsible of a wide range of side effects. The investigators use VigiBase, the World Health Organization (WHO) database of individual safety case reports, to identify cases of adverse drug reactions following treatment with radiopharmaceuticals drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Radiopharmaceuticals drugs | radiopharmaceuticals drugs included in the Anatomical Therapeutic Chemical (ATC) classification system. |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2024-07-03
- Last updated
- 2024-07-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06483685. Inclusion in this directory is not an endorsement.